Table 1. Countries and surveys included in the study.
Country | Survey year | Number of facilitiessurveyed | Number of essentialmedicines surveyed/Totalno. of surveyed medicines | WHO region | WB income group* | Gini Index** | Gini Index (year) |
Bolivia | 2008 | 60 | 42/50 | Americas | LMIC | 56.29 | 2008 |
Brazil | 2008 | 56 | 43/50 | Americas | UMIC | 55.07 | 2008 |
Cameroon | 2005 | 60 | 25/36 | Africa | LIC | 38.91 | 2007 |
Chad | 2004 | 43 | 18/22 | Africa | LIC | 39.78 | 2003 |
China | 2010 | 86 | 33/47 | Western Pacific | UMIC | 42.48 | 2005 |
Congo, Rep. | 2007 | 58 | 28/32 | Africa | LMIC | 47.32 | 2005 |
Ethiopia | 2004 | 87 | 44/47 | Africa | LIC | 29.83 | 2005 |
Ghana | 2004 | 112 | 36/49 | Africa | LIC | 42.76 | 2006 |
Indonesia | 2010 | 153 | 43/50 | South-East Asia | LMIC | 34.01 | 2005 |
Kenya | 2004 | 157 | 33/45 | Africa | LIC | 47.68 | 2005 |
Malaysia | 2004 | 72 | 23/47 | Western Pacific | UMIC | 37.91 | 2004 |
Mali | 2004 | 64 | 35/37 | Africa | LIC | 38.99 | 2006 |
Mexico | 2009 | 28 | 38/42 | Americas | UMIC | 48.28 | 2008 |
Nicaragua | 2008 | 105 | 30/43 | Americas | LMIC | 40.47 | 2005 |
Nigeria | 2004 | 124 | 27/29 | Africa | LIC | 42.93 | 2004 |
Pakistan | 2004 | 78 | 20/29 | Eastern Mediterranean | LIC | 31.18 | 2005 |
South Africa | 2004 | 45 | 35/42 | Africa | UMIC | 67.4 | 2006 |
Tajikistan | 2005 | 40 | 30/34 | Europe | LIC | 33.61 | 2004 |
Tanzania | 2004 | 111 | 29/44 | Africa | LIC | 37.58 | 2007 |
Thailand | 2006 | 41 | 40/43 | South-East Asia | LMIC | 42.35 | 2006 |
Uganda | 2004 | 60 | 32/45 | Africa | LIC | 42.62 | 2006 |
Yemen | 2006 | 40 | 17/35 | Eastern Mediterranean | LIC | 37.69 | 2005 |
India | 2003–2011 | 656 | 185/232 | South-East Asia | LIC† | 33.38 | 2005 |
*As at the time of the survey. LIC: low income country, LMIC: lower middle income country, UMIC: upper middle income country.
**Data is closest to the year of the survey.
2003–2005.